v3.26.1
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 225,943 $ 248,642
Patient accounts receivable, net 110,960 95,710
Prepaid expenses and other current assets 41,063 71,848
Total current assets 377,966 416,200
NONCURRENT ASSETS    
Property and equipment, net 164,696 161,583
Right-of-use assets 157,007 149,720
Intangible assets, net 172,805 177,665
Goodwill 1,304,556 1,293,346
Other noncurrent assets 4,466 5,419
Total noncurrent assets 1,803,530 1,787,733
Total assets 2,181,496 2,203,933
CURRENT LIABILITIES    
Accounts payable 11,053 6,122
Accrued payroll expenses 149,320 143,327
Other accrued expenses 49,551 42,187
Operating lease liabilities, current 46,500 45,544
Other current liabilities 18,329 14,782
Total current liabilities 274,753 251,962
NONCURRENT LIABILITIES    
Long-term debt, net 258,991 265,927
Operating lease liabilities, noncurrent 154,159 148,553
Deferred tax liability, net 16,408 16,408
Other noncurrent liabilities 37 68
Total noncurrent liabilities 429,595 430,956
Total liabilities 704,348 682,918
COMMITMENTS AND CONTINGENCIES (see Note 12)
STOCKHOLDERS' EQUITY    
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30,2026 and December 31, 2025; 0 shares issued and outstanding as of june 30,2026 and December 31,2025, respectively 0 0
Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2026 and December 31, 2025; 382,022 and 388,318 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 3,820 3,883
Additional paid-in capital 2,244,099 2,325,758
Accumulated deficit (770,771) (808,626)
Total stockholders' equity 1,477,148 1,521,015
Total liabilities and stockholders' equity $ 2,181,496 $ 2,203,933